Neomycin is generally safe for dogs when used topically for short periods, such as in ear drops, eye ointments, or skin creams. It becomes significantly riskier when given orally or by injection, where it can damage the kidneys and cause permanent hearing loss. The safety of neomycin depends almost entirely on how it’s being used, for how long, and whether your dog has certain pre-existing conditions.
How Neomycin Is Used in Dogs
Neomycin is an antibiotic in the aminoglycoside family. It’s one of the most common antibiotics found in veterinary topical products, often combined with other ingredients like polymyxin B and a steroid such as dexamethasone. You may recognize it from triple-antibiotic ointments or prescription ear and eye medications.
FDA-regulated veterinary products containing neomycin are approved for several topical uses in dogs:
- Eyes: superficial bacterial infections of the eyelid and conjunctiva, corneal injuries, and keratitis
- Ears: acute and chronic outer ear infections (otitis externa) and inflammatory conditions of the ear canal
- Skin: bacterial and inflammatory skin conditions, including hot spots, wound infections, anal gland infections, dermatitis between the toes, and minor cuts or abrasions
These topical applications carry relatively low risk because only small amounts of neomycin are absorbed into the bloodstream through intact skin or mucous membranes. The serious safety concerns arise when neomycin enters the body in larger quantities, either through oral dosing, injection, or absorption through damaged tissue.
Kidney Damage and Hearing Loss
Neomycin is the most toxic aminoglycoside antibiotic to mammalian cells. When it reaches the bloodstream in significant amounts, it can cause two major types of harm: kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Both risks increase with higher doses, longer treatment courses, and dosing more than once per day.
Kidney damage occurs because neomycin accumulates in kidney tissue. Repeated daily doses or overdoses can overwhelm the kidneys’ ability to clear the drug. The risk climbs sharply if a dog already has compromised kidney function, gut inflammation that allows more of the drug to be absorbed, or is taking other medications that stress the kidneys.
Hearing loss happens because neomycin destroys sensory hair cells in the inner ear. These cells don’t regenerate. The damage typically starts with high-frequency hearing and progresses to lower frequencies as exposure continues. It’s bilateral, meaning both ears are affected, and it’s essentially irreversible. Newborn puppies and older dogs face greater risk. Neomycin can also cross the placental barrier, posing a threat to unborn puppies in pregnant dogs.
Why Oral Neomycin Is No Longer Recommended
Veterinarians once prescribed oral neomycin for dogs with liver disease, specifically to reduce ammonia-producing bacteria in the gut that contribute to hepatic encephalopathy, a condition where toxins build up and affect the brain. That practice has fallen out of favor. The Merck Veterinary Manual now explicitly advises against oral neomycin for liver patients, noting that chronic absorption of even small amounts puts dogs at risk for both kidney injury and hearing loss. This has been documented in dogs and cats with congenital liver shunts. Safer alternatives for managing hepatic encephalopathy have replaced it.
Dogs That Should Not Receive Neomycin
Certain dogs face heightened risk from neomycin even in topical form. Neomycin is contraindicated in dogs with known kidney problems, because any amount that gets absorbed puts additional strain on already-compromised kidneys. Dogs with gastrointestinal inflammation should also avoid oral neomycin, since inflamed gut tissue absorbs more of the drug into the bloodstream than healthy tissue would.
Avoid neomycin-containing eye products if your dog has a corneal ulcer, as the combination products often contain steroids that can worsen ulcers. Dogs with a known allergy to any component of the medication should not use it either. If you notice increased redness, swelling, or irritation at the application site after starting treatment, that may signal an allergic reaction rather than improvement.
Medications That Increase the Risk
Several common medications make neomycin more dangerous when used at the same time. NSAIDs (non-steroidal anti-inflammatory drugs like carprofen or meloxicam, frequently prescribed for arthritis or pain) can stress the kidneys and amplify neomycin’s nephrotoxic effects. Loop diuretics, especially furosemide, are particularly concerning because they potentiate hearing damage when combined with aminoglycosides, potentially causing profound, permanent hearing loss.
Other drugs that raise risk include certain antifungal medications and some anesthetics. If your dog is about to undergo surgery, the combination of neomycin with gas anesthetics and muscle relaxants can increase the chance of neuromuscular blockade, which means temporary muscle weakness or, in rare cases, breathing difficulty. Make sure your veterinarian knows about any neomycin product your dog is currently using before any procedure.
Keeping Topical Use Safe
For the vast majority of dogs, a short course of a neomycin-containing ear drop, eye ointment, or skin cream prescribed by a veterinarian is safe and effective. The key factors that keep risk low are short duration, correct dosing, and making sure your dog doesn’t have kidney disease or other contraindications.
A few practical things to keep in mind: use an Elizabethan collar (cone) if your dog tries to lick topical neomycin off their skin, since ingesting the medication increases systemic absorption. Follow the prescribed treatment length and don’t extend it on your own, even if the condition hasn’t fully resolved. If your dog is on any other medications, especially NSAIDs or diuretics, mention it before starting neomycin. And watch for signs of an adverse reaction at the application site, including worsening redness, swelling, or discharge, which could indicate either an allergy or that the infection isn’t responding to treatment.